The Neurodevelopmental and Molecular Landscape of Medulloblastoma Subgroups: Current Targets and the Potential for Combined Therapies
Medulloblastoma is the most common malignant pediatric brain tumor and is associated with significant morbidity and mortality in the pediatric population. Despite the use of multiple therapeutic approaches consisting of surgical resection, craniospinal irradiation, and multiagent chemotherapy, the p...
Main Authors: | Hasan Slika, Paolo Alimonti, Divyaansh Raj, Chad Caraway, Safwan Alomari, Eric M. Jackson, Betty Tyler |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/15/3889 |
Similar Items
-
Molecular and clinical correlates of medulloblastoma subgroups: A narrative review
by: Hallie Coltin, et al.
Published: (2021-01-01) -
Advances in Immunohistochemical Markers in Molecular Classification of Medulloblastoma
by: ZHAO Hongyu, et al.
Published: (2018-04-01) -
Molecular subgrouping of medulloblastoma in pediatric population using the NanoString assay and comparison with immunohistochemistry methods
by: Joo Whan Kim, et al.
Published: (2022-11-01) -
Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups
by: Emilia Bevacqua, et al.
Published: (2021-12-01) -
A simplified approach using Taqman low-density array for medulloblastoma subgrouping
by: Gustavo Alencastro Veiga Cruzeiro, et al.
Published: (2019-03-01)